Hjem › Rabdomiosarkom › Massachusetts
Kliniske studier for Rabdomiosarkom i Massachusetts
4 studier for Rabdomiosarkom søker deltakere på steder i Massachusetts.
Byer i Massachusetts
Offisiell studietekst (engelsk)
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Dana-Farber Cancer Institute, Boston
- UMass Memorial Medical Center - University Campus, Worcester
RekruttererFase 3
Opp til 50 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT07466316PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
RekruttererFase 1/2
Alder 1 til 30 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT06721689VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- Boston Children's Hospital, Boston
RekruttererFase 1/2
6 Months – 30 Years · Alle kjønn · Oppdatert 2. jun. 2026 · NCT04796012Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
RekruttererFase 1/2
Alder 12 til 49 · Alle kjønn · Oppdatert 19. feb. 2026 · NCT06709495Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.